Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

Benzinga Newsdesk www.benzinga.com Positive 86.6%

Neg 0% Neu 0% Pos 86.6%

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.